Are Adverse Events Attributed to Essure Associated With Nickel Sensitization?


Journal

Dermatitis : contact, atopic, occupational, drug
ISSN: 2162-5220
Titre abrégé: Dermatitis
Pays: United States
ID NLM: 101207335

Informations de publication

Date de publication:
Historique:
entrez: 14 3 2020
pubmed: 14 3 2020
medline: 6 1 2021
Statut: ppublish

Résumé

Essure is an effective method for hysteroscopic sterilization. Reports of adverse effects, the underlying mechanisms of which are unknown, have increased in recent years. The aim of the study was to determine whether there is a relationship between adverse events attributed to Essure and nickel sensitization. Patients presenting alleged adverse reactions to Essure were referred for nickel patch testing before removal. Data regarding medical history of nickel sensitization and symptoms attributed to Essure were collected. Dimethylglyoxime spot tests were performed on the explanted Essure. There was a follow-up at 3 months to evaluate whether there is improvement of the symptoms after Essure removal. Nickel sensitization via the classic delayed hypersensitivity pathway did not seem to be responsible for adverse events attributed to Essure. Among systemic symptoms reported, extracutaneous symptoms had the highest prevalence. Systemic contact dermatitis to nickel could not be ruled out in one case.

Sections du résumé

BACKGROUND BACKGROUND
Essure is an effective method for hysteroscopic sterilization. Reports of adverse effects, the underlying mechanisms of which are unknown, have increased in recent years.
OBJECTIVE OBJECTIVE
The aim of the study was to determine whether there is a relationship between adverse events attributed to Essure and nickel sensitization.
METHODS METHODS
Patients presenting alleged adverse reactions to Essure were referred for nickel patch testing before removal. Data regarding medical history of nickel sensitization and symptoms attributed to Essure were collected. Dimethylglyoxime spot tests were performed on the explanted Essure. There was a follow-up at 3 months to evaluate whether there is improvement of the symptoms after Essure removal.
CONCLUSIONS CONCLUSIONS
Nickel sensitization via the classic delayed hypersensitivity pathway did not seem to be responsible for adverse events attributed to Essure. Among systemic symptoms reported, extracutaneous symptoms had the highest prevalence. Systemic contact dermatitis to nickel could not be ruled out in one case.

Identifiants

pubmed: 32168143
doi: 10.1097/DER.0000000000000489
pii: 01206501-202003000-00006
doi:

Substances chimiques

Allergens 0
Oximes 0
dimethylglyoxime 2971MFT1KY
nickel sulfate 4FLT4T3WUN
Nickel 7OV03QG267

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-127

Auteurs

Nadia Raison-Peyron (N)

From the Department of Dermatology, Allergology Unit.

Aurélie Du-Thanh (A)

From the Department of Dermatology, Allergology Unit.

Clara Compan (C)

Department of Gynecology, Arnaud de Villeneuve Hospital.

Hélène Perrochia (H)

Pathology Department, Gui de Chauliac Hospital.

Sarah Francini (S)

Department of Gynecology, Arnaud de Villeneuve Hospital.

Claire Duflos (C)

Medical Information Department, Univ Montpellier, CHU Montpellier, Montpellier, France.

Patrice Crochet (P)

Department of Gynecology, Arnaud de Villeneuve Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH